Last updated on 26 Oct 2021
Owner Info
Xeris Pharmaceuticals, Inc.
180 N LaSalle Street, Suite 1810
Chicago IL 60601, UNITED STATES OF AMERICA
Serial Number
2201871 filed on 3 Jun 2021
Correspondent
Tracy-Gene G. Durkin Sterne, Kessler, Goldstein & Fox P.L.L.C.
1100 New York Avenue, NW,
Washington DC 20005,
UNITED STATES OF AMERICA
2201871
3 Jun 2021
3 Jun 2031
WORD
4 Dec 2020
US
Status Date | Action Taken |
---|---|
26th Oct 2021 | International Registration in Australia Protected correspondence sent |
25th Oct 2021 | IP Right Registration Published |
25th Oct 2021 | Status change to Registered/Protected |
17th Aug 2021 | Application Accepted correspondence sent |
16th Aug 2021 | IP Right has been Examined |
16th Aug 2021 | IP Right Acceptance Published |
16th Aug 2021 | Status change to Accepted |
13th Aug 2021 | Awaiting examination |
13th Aug 2021 | Examination expedited |
12th Aug 2021 | IP Right Filed Published |